Hikma/Sanofi Lovenox/Biodel?, page-2

Hikma is ramping as confirmed by their Annual report. Sanofi Lovenox is supposedly being released in spring 2016 in our PFS. Biodel looks like the registration lot won't be ready till 3Q 2016. Sanofi wearable is heading into clinical trials sometime in 4Q and commercial production in 3Q 2016.

Piper did a deep dive into Unilife and came up with the following EPS.

2016 -.01
2017 .17
2018 .90
2019 1.21

(EPS is based on UNS's FY which is July 1 - June 30)

These numbers are based on Sanofi Lovenox, Sanofi Wearable, and Hikma.

Remember this is looking at a Chrystal ball but the analyst seemed to have an understanding what Sanofi and Hikma have the capability to do sales wise and estimated accordingly.